Cite
A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial
MLA
Offner, F.Robak, T.Janssens, A.Govind Babu, K.Kloczko, J.Grosicki, S.Mayer, J.Panagiotidis, P.Schuh, A.Pettitt, A.Montillo, M.Werner, O.Vincent, G.Khanna, S.Hillmen, P. A Five-Year Follow-up of Untreated Patients with Chronic Lymphocytic Leukaemia Treated with Ofatumumab and Chlorambucil: Final Analysis of the Complement 1 Phase 3 Trial. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..6526bad1d480b89e30a40b2625d22ea6&authtype=sso&custid=ns315887.
APA
Offner, F. R. T. J. A. G. B. K. K. J. G. S. M. J. P. P. S. A. P. A. M. M. W. O. V. G. K. S. H. P. (2020). A five-year follow-up of untreated patients with chronic lymphocytic leukaemia treated with ofatumumab and chlorambucil: final analysis of the Complement 1 phase 3 trial.
Chicago
Offner, F. Robak, T. Janssens, A. Govind Babu, K. Kloczko, J. Grosicki, S. Mayer, J. Panagiotidis, P. Schuh, A. Pettitt, A. Montillo, M. Werner, O. Vincent, G. Khanna, S. Hillmen, P. 2020. “A Five-Year Follow-up of Untreated Patients with Chronic Lymphocytic Leukaemia Treated with Ofatumumab and Chlorambucil: Final Analysis of the Complement 1 Phase 3 Trial,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..6526bad1d480b89e30a40b2625d22ea6&authtype=sso&custid=ns315887.